4.7 Article Proceedings Paper

Esophageal disease: updated information on inflammation

Journal

Publisher

BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2011.06064.x

Keywords

tight junction; adherens junction; claudins; e-cadherin; paracellular permeability; dilated intercellular spaces; esophagitis; gastro-esophageal reflux; squamous cells; TRPV-1 receptor; platelet activating factor; substance P; cytokines; inflammatory mediators; nonerosive reflux disease; chemosensitive nociceptors; inflammatory mediators; adenocarcinoma; NOX5-S; TGR5

Funding

  1. NIDDK [R01 DK080703]

Ask authors/readers for more resources

The following on esophageal disease provides updated information the mucosal defense against acid and acid-pepsin injury; the roles of platelet activating factor, mast cells, proinflammatory cytokines, and chemokines in inflammation; differences and similarities in erosive and nonerosive esophagitis; acid and vanilloid receptors in esophageal mucosa; and bile acid receptors in esophageal epithelium.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Assessment of core and support functions of the communicable disease surveillance system in the Kurdistan Region of Iraq

Soran Amin Hamalaw, Ali Hattem Bayati, Muhammed Babakir-Mina, Domenico Benvenuto, Silvia Fabris, Michele Guarino, Marta Giovanetti, Massimo Ciccozzi

Summary: Early detection and prompt response are crucial in preventing and controlling outbreaks. This study evaluates the performance of the Communicable Disease Surveillance System (CDSS) in the Kurdistan region of Iraq, finding deficiencies in surveillance guiding manuals, data analysis, epidemic preparedness, feedback, and standard guidelines. Strengthening the CDSS in this region requires continuous feedback, supervision, well-trained staff, and coordination between researchers and physicians.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Cell Biology

The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period

Francesco Valentini, Giulia Rocchi, Umberto Vespasiani-Gentilucci, Michele Pier Luca Guarino, Annamaria Altomare, Simone Carotti

Summary: Fetal life and the first few months after birth are crucial periods for adaptation to environmental conditions and can have long-term metabolic consequences and impact on gut microbiota composition, thus affecting future health.

CELLS (2022)

Review Microbiology

Gut Microbiota and COVID-19: Potential Implications for Disease Severity

Giulia Rocchi, Marta Giovanetti, Francesca Benedetti, Alessandra Borsetti, Giancarlo Ceccarelli, Davide Zella, Annamaria Altomare, Massimo Ciccozzi, Michele Pier Luca Guarino

Summary: The SARS-CoV-2 pandemic has caused an unprecedented global crisis. The virus primarily infects the lungs by binding to the ACE-2 cell receptor on the surface of alveolar epithelial cells. Interestingly, this receptor is also found in the epithelial cells of the intestinal tract. Recent data suggests that the gut microbiota may play a role in modulating inflammation. Gastrointestinal symptoms, including diarrhea, are often observed in infected individuals, and there is evidence that the virus can spread through fecal-oral transmission.

PATHOGENS (2022)

Review Nutrition & Dietetics

The Role of Dietary Fibers in the Management of IBD Symptoms

Claudia Di Rosa, Annamaria Altomare, Elena Imperia, Chiara Spiezia, Yeganeh Manon Khazrai, Michele Pier Luca Guarino

Summary: Inflammatory bowel diseases, including Chron's disease and ulcerative colitis, are chronic immune-mediated diseases of the intestinal tract. Dietary therapy has been shown to be crucial in managing symptoms and pathology of IBD, although there is currently no specific therapeutic diet. Further research is needed to determine the appropriate amount and type of fiber intake for IBD patients.

NUTRIENTS (2022)

Review Nutrition & Dietetics

Protective Role of Natural Compounds under Radiation-Induced Injury

Annamaria Altomare, Michele Fiore, Gabriele D'Ercole, Elena Imperia, Roberta Maria Nicolosi, Susanna Della Posta, Gabriella Pasqua, Michele Cicala, Laura De Gara, Sara Ramella, Michele Pier Luca Guarino

Summary: Radiotherapy-induced mucositis (RIOM) is a common side effect of anti-neoplastic treatments, affecting patients' quality of life and treatment response. Recent evidence suggests that natural compounds can potentially prevent and treat this damage without compromising treatment efficacy.

NUTRIENTS (2022)

Review Microbiology

The Role of Gut Bacteriome in Asthma, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea

Andras Bikov, Silvano Dragonieri, Balazs Csoma, Carmen Mazzuca, Panaiotis Finamore, Giulia Rocchi, Lorenza Putignani, Michele Guarino, Simone Scarlata

Summary: The bacteria in the human body, especially the gut microbiome, play an important role in respiratory diseases such as bronchial asthma, chronic obstructive pulmonary disease, and obstructive sleep apnea. This article summarizes the evidence and discusses the impact of altered gut microbiome on these diseases and their comorbidities, as well as the potential of manipulating the gut microbiome for therapeutic purposes.

MICROORGANISMS (2022)

Article Gastroenterology & Hepatology

Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients

Alessandra Lo Presti, Federica Del Chierico, Annamaria Altomare, Francesca Zorzi, Giovanni Monteleone, Lorenza Putignani, Silvia Angeletti, Michele Cicala, Michele Pier Luca Guarino, Massimo Ciccozzi

Summary: This study investigated the phylogenetic dynamics of P. copri in patients with IBS, IBD, and healthy volunteers. Results showed longer genetic distances between IBD and healthy volunteers, as well as between IBD and IBS, indicating higher genetic variability in P. copri sequences within IBD. Different strains of P. copri were found in IBS patients, and a correlation between isolates and disease grading was observed. Understanding the phylogenetic characteristics of P. copri is important for better understanding the interactions between microbiota and the pathophysiology of IBD and IBS.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

Article Nutrition & Dietetics

Early impairment of food intake in patients newly diagnosed with cancer

Alessio Molfino, Sara Emerenziani, Giuseppe Tonini, Daniele Santini, Antonietta Gigante, Michele Pier Luca Guarino, Chiara Nuglio, Giovanni Imbimbo, Annalisa La Cesa, Michele Cicala, Maurizio Muscaritoli

Summary: This study evaluated the prevalence of anorexia, hypophagia, and cachexia in patients with gastrointestinal or lung cancer at time of diagnosis. The results showed that 68% of patients had cachexia, 57% had anorexia, and 48% had hypophagia. These conditions had negative impacts on patients' nutritional intake, indicating a need for early multimodal strategies to improve food intake.

FRONTIERS IN NUTRITION (2023)

Review Nutrition & Dietetics

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Claudia Di Rosa, Annamaria Altomare, Vittoria Terrigno, Florencia Carbone, Jan Tack, Michele Cicala, Michele Pier Luca Guarino

Summary: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and altered bowel habits. The exact cause of IBS is not fully understood, but it is believed to involve a combination of factors such as abnormal gut motility, inflammation, increased intestinal permeability, and sensitivity. Diet and gut microbiota have also been identified as important contributors to IBS. This review examines the effects of dietary components, functional foods, prebiotics, probiotics, and symbiotics on symptoms and gut microbiota in individuals with IBS-C.

NUTRIENTS (2023)

Meeting Abstract Gastroenterology & Hepatology

REDUCED ADHERENCE TO MEDITERRANEAN DIET AND INTESTINAL MICROBIOTA COMPOSITION IN INFLAMMATORY BOWEL DISEASE PATIENTS

A. Altomare, G. Rocchi, F. Zorzi, F. Del Chierico, A. Lo Presti, S. Emerenziani, C. Nuglio, L. Pica, M. Ciccozzi, L. Putignani, M. Cicala, M. P. L. Guarino

DIGESTIVE AND LIVER DISEASE (2022)

No Data Available